Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Peak bone mass in young HIV-infected patients compared with healthy controls.
Negredo E, Domingo P, Ferrer E, Estrada V, Curran A, Navarro A, Isernia V, Rosales J, Pérez-Álvarez N, Puig J, Bonjoch A, Echeverría P, Podzamczer D, Clotet B. Negredo E, et al. Among authors: echeverria p. J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):207-12. doi: 10.1097/01.qai.0000435598.20104.d6. J Acquir Immune Defic Syndr. 2014. PMID: 24091689
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
Echeverría P, Negredo E, Carosi G, Gálvez J, Gómez JL, Ocampo A, Portilla J, Prieto A, López JC, Rubio R, Mariño A, Pedrol E, Viladés C, del Arco A, Moreno A, Bravo I, López-Blazquez R, Pérez-Alvarez N, Clotet B. Echeverría P, et al. Antiviral Res. 2010 Feb;85(2):403-8. doi: 10.1016/j.antiviral.2009.11.008. Epub 2009 Nov 24. Antiviral Res. 2010. PMID: 19941906 Clinical Trial.
Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.
Negredo E, Massanella M, Puertas MC, Buzón MJ, Puig J, Pérez-Alvárez N, Pérez-Santiago J, Bonjoch A, Moltó J, Jou A, Echeverría P, Llibre JM, Martínez-Picado J, Clotet B, Blanco J. Negredo E, et al. Among authors: echeverria p. J Antimicrob Chemother. 2013 Oct;68(10):2358-62. doi: 10.1093/jac/dkt183. Epub 2013 May 14. J Antimicrob Chemother. 2013. PMID: 23677919 Free PMC article. Clinical Trial.
Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study.
Echeverría P, Bonjoch A, Puig J, Moltó J, Paredes R, Sirera G, Ornelas A, Pérez-Álvarez N, Clotet B, Negredo E. Echeverría P, et al. PLoS One. 2014 Feb 4;9(2):e84676. doi: 10.1371/journal.pone.0084676. eCollection 2014. PLoS One. 2014. PMID: 24503952 Free PMC article. Clinical Trial.
Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study).
Negredo E, Domingo P, Pérez-Álvarez N, Gutiérrez M, Mateo G, Puig J, Escrig R, Echeverría P, Bonjoch A, Clotet B. Negredo E, et al. Among authors: echeverria p. J Antimicrob Chemother. 2014 Dec;69(12):3368-71. doi: 10.1093/jac/dku300. Epub 2014 Aug 13. J Antimicrob Chemother. 2014. PMID: 25125679 Clinical Trial.
High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.
Bonjoch A, Juega J, Puig J, Pérez-Alvarez N, Aiestarán A, Echeverría P, Pérez V, Clotet B, Romero R, Bonet J, Negredo E. Bonjoch A, et al. Among authors: echeverria p. AIDS Patient Care STDS. 2014 Oct;28(10):524-9. doi: 10.1089/apc.2014.0172. Epub 2014 Sep 19. AIDS Patient Care STDS. 2014. PMID: 25238104 Free article.
330 results